-->

nDatalyze Corp. Announces Appointment of Commercial Sales Director for the Epitome Hockey Platform.



nDatalyze Corp.

CALGARY, AB – April 27, 2026 - TheNewswirenDatalyze Corp. (CSE: NDAT) (OTC: NDATF) (the “Company” or “nDatalyze”) is pleased to announce the appointment of Nicholas Domitrovic as Commercial Sales Director for its Epitome hockey performance predisposition platform called Epitome Predispositions.

Mr. Domitrovic is a recently retired professional hockey player with international experience in France’s FFHG Division 1. A former dual-sport NCAA athlete in hockey and golf, he served as captain of both programs and earned recognition as a four-year All-Academic Conference selection and Academic All-American. He previously served as a Lead Ice Hockey Instructor at Bell Sensplex and as President of the Mental Health Club at Elmira College in New York.

Mr. Domitrovic holds a Bachelor of Arts in Business Administration (minor in Finance) and is currently pursuing a Master of Applied Health Science (Sports Management) at Brock University, where he plays hockey for the Brock University Badgers. The Badgers were among the teams involved in the development of the Epitome hockey application.

James Durward, President of nDatalyze, states: “Epitome has broad applicability across human performance metrics, from sport through business, and Nick is a natural fit to lead Epitome’s commercialization both in hockey and other prospective fields. His initial responsibilities will include redesigning the marketing platform and website, as well as onboarding hockey academies, schools, and junior league teams to the platform.”

Reverse Takeover (“RTO”) Update

The Company remains committed to completing its previously announced reverse takeover transaction (the “RTO”) and is currently finalizing the terms and conditions of a definitive agreement. Investors are reminded that only shareholders of nDatalyze as of the date of the anticipated trading halt—expected to occur upon announcement of the execution of the definitive agreement—will be entitled to receive shares of the private Epitome entity to be spun out upon closing of the RTO.

About nDatalyze Corp.

nDatalyze Corp. is a technology company focused on developing health and performance-related solutions through the application of advanced artificial intelligence and biometric data analytics.

For Further Information, please contact:

 

Jim Durward, President, CEO/CTO

Email: jimd@ndatalyze.com  

Tel: (403) 689-3901

nDatalyze Website: https://www.ndatalyze.com      

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.